Do novel biomarkers add to existing scores of total cardiovascular risk?

European Journal of Preventive Cardiology

Volumn 19, Issue , 2012, Pages 14-17

  de Backer, Guy ^a   Graham, Ian ^b   Cooney, Marie Therese ^b  

^a GHENT UNIVERSITY   (Belgium)

^b ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

Cardiovascular disease; genetic markers; lipids; risk assessment; risk factors

Indexed keywords

AUTACOID; BIOLOGICAL MARKER; LIPID;

ALGORITHM; BLOOD; CARDIOVASCULAR DISEASE; DECISION SUPPORT SYSTEM; EVIDENCE BASED MEDICINE; GENETIC MARKER; GENETICS; HUMAN; PERSONALIZED MEDICINE; PREVENTIVE HEALTH SERVICE; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL;

ALGORITHMS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DECISION SUPPORT TECHNIQUES; EVIDENCE-BASED MEDICINE; GENETIC MARKERS; HUMANS; INDIVIDUALIZED MEDICINE; INFLAMMATION MEDIATORS; LIPIDS; MODELS, STATISTICAL; PREVENTIVE HEALTH SERVICES; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 84871703858     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487312448988     Document Type: Article

References (19)

1. Pyorala K, De Backer G, Graham I, et al. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 1994; 15: 1300–1331.
2. D’Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117: 743–753.
3. Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe:the SCORE project. Eur Heart J 2003; 24: 987–1003.
4. Woodward M, Brindle P, Tunstall-Pedoe H. Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart 2007; 93: 172–176.
5. Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 2008; 336: 1475–1482.
6. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) study. Circulation 2002; 105: 310–315.
7. Ridker PM, Paynter NP, Rifai N, et al. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation 2008; 118: 2243–2251.
8. Ridker PM, Buring JE, Rifai N, et al. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 2007; 297: 611–619.
9. Tunstall-Pedoe H. Cardiovascular risk and risk scores: ASSIGN, Framingham, QRISK and others: how to choose. Heart 2011; 97: 442–444.
10. Cooney M, Vartiainen E, Laatikainen T, et al. Simplifying risk estimation using resting heart rate. Paper presented at European Society of Cardiology Congress, Barcelona, Spain. 1 September 2009.
11. Cook NR, Buring JE, Ridker PM. The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med 2006; 145: 21–29.
12. Melander O, Newton-Cheh C, Almgren P, et al. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 2009; 302: 49–57.
13. Kim HC, Greenland P, Rossouw JE, et al. Multimarker prediction of coronary heart disease risk: the Women’s health initiative. J Am Coll Cardiol 2010; 55: 2080–2091.
14. Wang TJ, Gona P, Larson MG, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006; 355: 2631–2639.
15. Shlipak MG, Fried LF, Cushman M, et al. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 2005; 293: 1737–1745.
16. Folsom AR, Chambless LE, Ballantyne CM, et al. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers. Arch Intern Med 2006; 166: 1368–1373.
17. Zethelius B, Berglund L, Sundstrom J, et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008; 358: 2107–2116.
18. Cooney M, Dudina A, De Bacquer D, et al. How much does HDL cholesterol add to risk estimation? A report from the SCORE investigators. Eur J Cardiovasc Prev Rehabil 2009; 16: 304–314.
19. Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157–172. Discussion 207–212.